[Fibrinolytic treatment of acute respiratory insufficiency (shock lung) after diagnostic amniocentesis with septic shock].
D000032:Abortion, Therapeutic; D000328:Adult; D000649:Amniocentesis / Q000009:adverse effects*; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007565:Jaundice / Q000209:etiology; D011030:Pneumothorax / Q000209:etiology; D011175:Positive-Pressure Respiration; D011247:Pregnancy; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D012772:Shock, Septic / Q000209:etiology; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator
Fibrinolytische Behandlung der akuten respiratorischen Insuffizienz ("Schocklunge") nach diagnostischer Amniozentese mit septischem Schock.